Palantir (NASDAQ: PLTR) just delivered another beat-and-raise quarter, and Wall Street moved quickly to refresh its models. Below is a crisp roundup of the latest price targets and ratings from major brokers as of November 5, 2025, plus what the evolving consensus says about upside versus a still-demanding valuation.
The Very Latest Calls (past 2–3 days)
- Bank of America (Buy): $255
BofA cites accelerating adoption of Palantir’s AI platform and a “differentiated” go-to-market (bootcamps + FDEs). New top-of-street target. - Wedbush (Outperform): $230
Raises target on AI momentum, large deal flow, and a path to $1T TAM narratives that keep compounding into 2026. - Morgan Stanley (Equal Weight): $205
Acknowledges ninth straight quarter of accelerating growth and “monumental bookings,” but sticks to a market-weighted stance given valuation. - Deutsche Bank (Hold): $200
Lifts target post-print; comfortable with growth and profitability, less so with multiple expansion from here. - Piper Sandler (Overweight): $225
Stays bullish on execution and AI monetization curve. - Mizuho (Neutral): $205
Sees fundamentals improving but thinks much is in the price. - DA Davidson (Neutral): $215
Ups target on faster AI traction; prefers to wait for a better entry. - Citi (Neutral): $190
Nudges target higher ahead of/after results, but keeps rating balanced. - RBC (Underperform): $50
Holds a notably skeptical view, arguing the multiple far exceeds underlying long-term cash flow potential. - UBS (Neutral): $205
Balanced view: impressive growth, but valuation discipline warranted. - Cantor (Neutral): $198
PT lifted; wants more evidence that recent U.S. commercial strength is durable globally.
Consensus Snapshot (today)
- Average 12-month price target: ~$169
- Range: Low $50 — High $255
- Skew: Higher cluster between $190–$230, with a long bearish tail from RBC anchoring the low.
- Ratings mix (directional): Bulls (Buy/Outperform) vs. Fencesitters (Hold/Neutral) vs. Bears (Underperform/Sell) remains roughly balanced, with a slight bias toward Hold/Neutral overall.
What’s Driving the Revisions
- Beat-and-raise fundamentals. Q3 showed rapid top-line growth and stronger commercial momentum in the U.S., prompting model upgrades to FY25–26 revenue and FCF.
- AI monetization curve. Bootcamps/AIP land-and-expand is scaling, lifting multi-year bookings and near-term billings visibility.
- Valuation gravity. Many upgrades lifted targets, not ratings. Even constructive analysts flag a rich multiple versus software peers, keeping several at Neutral/Equal Weight/Hold.
- Durability questions. Skeptics worry about (i) concentration in U.S. commercial/government, (ii) potential pull-forward in mega deals, and (iii) how fast international can catch up.
Bull vs. Bear: How to Read the Tape
- Bull case (e.g., BofA, Wedbush, Piper): Palantir is setting the agenda in enterprise AI, with a product + services stack competitors can’t easily copy. If revenue compounders persist and operating leverage holds, today’s multiple can be worked down.
- Bear case (e.g., RBC): Even with stellar growth, PLTR trades at hyper-premium sales/FCF multiples. Any deceleration, macro wobble, or U.S. budget hiccup could compress the multiple sharply.
- Centrist view (e.g., Morgan Stanley, Deutsche, Mizuho, Citi, UBS): Love the momentum, respect the multiple. They lifted targets to reflect better numbers but largely stayed neutral on risk-reward at current prices.
Investor Takeaway
The Street’s upper band has moved to $255, with a thick cluster in the $200± range that implicitly assumes continued 50%+ growth near term and sustained 30%+ FCF margins. If Palantir keeps printing beat-and-raise quarters and broadening internationally, $200–$230 targets look defendable. If growth normalizes sooner or bookings prove lumpy, the consensus (~$169) suggests room for a multiple reset. Position sizing and time horizon are key: bulls are paying for scarcity in enterprise AI; bears are betting gravity still works.
FAQ
What is the highest current price target on PLTR?
$255 (Buy).
What is the lowest current target?
$50 (Underperform).
Where do most targets cluster?
Between $190 and $230 with a consensus near $169.
Did many ratings change from Neutral to Buy?
No. Most brokers raised targets but held ratings steady (Neutral/Equal Weight/Hold), citing valuation.
What could push targets higher from here?
Sustained >50% revenue growth, international catch-up, expanding AI use cases, and continued FCF outperformance.
What could push targets lower?
Deal timing/pull-forward, slower U.S. commercial, macro/government spending softness, or a sector-wide multiple compression.
Disclaimer
This article is for information and commentary only and does not constitute investment advice. It is not a solicitation to buy or sell any security. Estimates, targets, and ratings are subject to change without notice. Perform your own research and consider consulting a qualified financial advisor.
